,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1342522,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0004096,HTH-type transcriptional regulator TtgR,https://www.drugbank.ca/bio_entities/BE0004096,Q9AIU0,HTH-type transcriptional regulator TtgR,,,1196325,Pseudomonas putida DOT-T1E,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1,1342523,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000123,Estrogen receptor,https://www.drugbank.ca/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606,Homo sapiens (human),,,,PMID:9751507|PMID:10397250,https://www.ncbi.nlm.nih.gov/pubmed/9751507|https://www.ncbi.nlm.nih.gov/pubmed/10397250,9751507|10397250,,
2,1342524,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000126,Aldo-keto reductase family 1 member C1,https://www.drugbank.ca/bio_entities/BE0000126,Q04828,Aldo-keto reductase family 1 member C1,1645.0,AKR1C1,9606,Homo sapiens (human),Antagonist,,,PMID:16962702,https://www.ncbi.nlm.nih.gov/pubmed/16962702,16962702,,
3,1342710,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0001111,Cytochrome P450 1B1,https://www.drugbank.ca/bio_entities/BE0001111,Q16678,Cytochrome P450 1B1,1545.0,CYP1B1,9606,Homo sapiens (human),,,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930,,
4,1342711,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0009091,KAT8 regulatory NSL complex subunit 3,https://www.drugbank.ca/bio_entities/BE0009091,Q9P2N6,KAT8 regulatory NSL complex subunit 3,55683.0,KANSL3,9606,Homo sapiens (human),,,,PMID:24412302,https://www.ncbi.nlm.nih.gov/pubmed/24412302,24412302,,
5,1342712,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000685,Sex hormone-binding globulin,https://www.drugbank.ca/bio_entities/BE0000685,P04278,Sex hormone-binding globulin,6462.0,SHBG,9606,Homo sapiens (human),,,,PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/25349334,25349334,,
6,1342713,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0002090,Aromatase,https://www.drugbank.ca/bio_entities/BE0002090,P11511,Aromatase,1588.0,CYP19A1,9606,Homo sapiens (human),Inhibitor,,,PMID:9435150,https://www.ncbi.nlm.nih.gov/pubmed/9435150,9435150,,
7,1342714,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000792,Estrogen receptor beta,https://www.drugbank.ca/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606,Homo sapiens (human),Partial agonist,,,PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/9751507,9751507,,
8,1342715,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0001042,Solute carrier organic anion transporter family member 2B1,https://www.drugbank.ca/bio_entities/BE0001042,O94956,Solute carrier organic anion transporter family member 2B1 ,11309.0,SLCO2B1,9606,Homo sapiens (human),Inhibitor,,,PMID:15640378,https://www.ncbi.nlm.nih.gov/pubmed/15640378,15640378,,
9,1342716,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606,Homo sapiens (human),Downregulator,,,PMID:14980703|PMID:25685543|PMID:10583025|PMID:9821810,https://www.ncbi.nlm.nih.gov/pubmed/14980703|https://www.ncbi.nlm.nih.gov/pubmed/25685543|https://www.ncbi.nlm.nih.gov/pubmed/10583025|https://www.ncbi.nlm.nih.gov/pubmed/9821810,14980703|25685543|10583025|9821810,,
10,1342717,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000785,Multidrug resistance-associated protein 1,https://www.drugbank.ca/bio_entities/BE0000785,P33527,Multidrug resistance-associated protein 1 ,4363.0,ABCC1,9606,Homo sapiens (human),Inhibitor,,,PMID:11306701,https://www.ncbi.nlm.nih.gov/pubmed/11306701,11306701,,
11,1342718,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606,Homo sapiens (human),Inhibitor,,,PMID:15205350|PMID:15102949,https://www.ncbi.nlm.nih.gov/pubmed/15205350|https://www.ncbi.nlm.nih.gov/pubmed/15102949,15205350|15102949,,
12,1342719,439246,BindingDB,Naringenin,23419,"(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23419,2394,Alpha-amylase 1A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2394,P0DUB6,Alpha-amylase 1A ,278.0,AMY1C,9606,Homo sapiens (human),,,,PMID:18507367|DOI:10.1021/jm800115x,https://www.ncbi.nlm.nih.gov/pubmed/18507367|https://doi.org/10.1021/jm800115x,18507367,10.1021/jm800115x,
13,1694092,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),Naringenin inhibits the reaction [elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of daunorubicin]]|naringenin inhibits the reaction [ABCB1 protein results in decreased uptake of daunorubicin]|naringenin promotes the reaction [elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of rhodamine 123]],,,PMID:34217736,https://www.ncbi.nlm.nih.gov/pubmed/34217736,34217736,,
14,1694093,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),Naringenin results in increased expression of ABCB1 mRNA,,,PMID:19148864,https://www.ncbi.nlm.nih.gov/pubmed/19148864,19148864,,
15,1694094,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),Naringenin affects the reaction [ABCC1 protein results in increased uptake of leukotriene c4]|[glutathione co-treated with naringenin] inhibits the reaction [ABCC1 protein results in increased uptake of estradiol-17 beta-glucuronide]|glutathione promotes the reaction [naringenin results in increased activity of ABCC1 protein]|naringenin results in increased activity of ABCC1 protein|glutathione promotes the reaction [naringenin affects the reaction [ABCC1 protein results in increased uptake of leukotriene C4]],,,PMID:11306701,https://www.ncbi.nlm.nih.gov/pubmed/11306701,11306701,,
16,1694095,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),"Naringenin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione]|naringenin inhibits the reaction [ABCC1 protein results in decreased susceptibility to etoposide]|naringenin promotes the reaction [ABCC1 protein results in increased hydrolysis of adenosine triphosphate]",,,PMID:16156793,https://www.ncbi.nlm.nih.gov/pubmed/16156793,16156793,,
17,1694332,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),Naringenin promotes the reaction [ABCC1 protein results in increased uptake of glutathione],,,PMID:12485947,https://www.ncbi.nlm.nih.gov/pubmed/12485947,12485947,,
18,1694333,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606,Homo sapiens (human),Naringenin promotes the reaction [ABCC4 protein results in increased hydrolysis of adenosine triphosphate]|naringenin inhibits the reaction [ABCC4 protein results in increased export of cyclic GMP],,,PMID:16156793,https://www.ncbi.nlm.nih.gov/pubmed/16156793,16156793,,
19,1694334,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,10057,ABCC5,https://ctdbase.org/detail.go?type=gene&acc=10057,,,10057.0,ABCC5,9606,Homo sapiens (human),"Naringenin inhibits the reaction [ABCC5 protein results in decreased susceptibility to thioguanine]|naringenin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]",,,PMID:16156793,https://www.ncbi.nlm.nih.gov/pubmed/16156793,16156793,,
20,1694335,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,38,ACAT1,https://ctdbase.org/detail.go?type=gene&acc=38,,,38.0,ACAT1,9986,Oryctolagus cuniculus (rabbit),"[cholesterol, dietary co-treated with naringenin] affects the activity of ACAT1 protein",,,PMID:11396955,https://www.ncbi.nlm.nih.gov/pubmed/11396955,11396955,,
21,1694336,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,8005,Electrophorus electricus (electric eel),Naringenin results in decreased activity of ACHE protein,,,PMID:31194956,https://www.ncbi.nlm.nih.gov/pubmed/31194956,31194956,,
22,1694337,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606,Homo sapiens (human),Naringenin results in decreased activity of ACHE protein,,,PMID:14739537,https://www.ncbi.nlm.nih.gov/pubmed/14739537,14739537,,
23,1694338,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [dimethylnitrosamine results in increased expression of ACTA2 protein],,,PMID:14709902,https://www.ncbi.nlm.nih.gov/pubmed/14709902,14709902,,
24,1694339,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,575,ADGRB1,https://ctdbase.org/detail.go?type=gene&acc=575,,,575.0,ADGRB1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of ADGRB1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of ADGRB1 mrna|naringenin metabolite results in increased expression of ADGRB1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
25,1694340,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,10116,Rattus norvegicus (Norway rat),Naringenin binds to AFP protein,,,PMID:23013281|PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/23013281|https://www.ncbi.nlm.nih.gov/pubmed/25349334,23013281|25349334,,
26,1694341,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of AHR protein]|naringenin inhibits the reaction [tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARNT protein]],,,PMID:20450880,https://www.ncbi.nlm.nih.gov/pubmed/20450880,20450880,,
27,1694575,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090,Mus musculus (house mouse),Naringenin results in increased activity of AHR protein,,,PMID:17869316,https://www.ncbi.nlm.nih.gov/pubmed/17869316,17869316,,
28,1694576,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of AHR protein],,,PMID:14646185,https://www.ncbi.nlm.nih.gov/pubmed/14646185,14646185,,
29,1694577,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606,Homo sapiens (human),Naringenin binds to and results in decreased activity of AKR1C1 protein,,,PMID:16962702,https://www.ncbi.nlm.nih.gov/pubmed/16962702,16962702,,
30,1694578,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606,Homo sapiens (human),Naringenin results in decreased activity of AKR1C3 protein,,,PMID:19007764,https://www.ncbi.nlm.nih.gov/pubmed/19007764,19007764,,
31,1694579,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),Naringenin inhibits the reaction [bisphenol A results in increased activity of AKT1 protein],,,PMID:22692793,https://www.ncbi.nlm.nih.gov/pubmed/22692793,22692793,,
32,1694580,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of AKT1 protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
33,1694581,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10044,Phodopus sungorus,Naringenin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein],,,PMID:22850125,https://www.ncbi.nlm.nih.gov/pubmed/22850125,22850125,,
34,1694582,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [lead acetate results in decreased expression of AKT1 protein],,,PMID:36807407,https://www.ncbi.nlm.nih.gov/pubmed/36807407,36807407,,
35,1694583,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
36,1694584,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [[streptozocin co-treated with dietary fats co-treated with carboxymethylcellulose sodium] results in increased expression of ALB protein],,,PMID:31063766,https://www.ncbi.nlm.nih.gov/pubmed/31063766,31063766,,
37,1694768,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [tyloxapol results in decreased expression of ALB mrna],,,PMID:37076581,https://www.ncbi.nlm.nih.gov/pubmed/37076581,37076581,,
38,1694769,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein]|[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein,,,PMID:12650720,https://www.ncbi.nlm.nih.gov/pubmed/12650720,12650720,,
39,1694770,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of APAF1 mrna|naringenin metabolite results in increased expression of APAF1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of APAF1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
40,1694771,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606,Homo sapiens (human),Naringenin results in increased expression of APAF1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
41,1694772,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [APP protein modified form results in increased abundance of reactive oxygen species],,,PMID:15030205,https://www.ncbi.nlm.nih.gov/pubmed/15030205,15030205,,
42,1694773,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,358,AQP1,https://ctdbase.org/detail.go?type=gene&acc=358,,,358.0,AQP1,9606,Homo sapiens (human),Naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of AQP1 protein]|naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of AQP1 mrna],,,PMID:31301536,https://www.ncbi.nlm.nih.gov/pubmed/31301536,31301536,,
43,1694774,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,362,AQP5,https://ctdbase.org/detail.go?type=gene&acc=362,,,362.0,AQP5,9606,Homo sapiens (human),Naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of AQP5 protein]|naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of AQP5 mrna],,,PMID:31301536,https://www.ncbi.nlm.nih.gov/pubmed/31301536,31301536,,
44,1694775,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,396,ARHGDIA,https://ctdbase.org/detail.go?type=gene&acc=396,,,396.0,ARHGDIA,9606,Homo sapiens (human),Naringenin results in increased expression of ARHGDIA mrna|naringenin results in increased expression of ARHGDIA protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
45,1694776,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of ARNT protein]|naringenin inhibits the reaction [tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARNT protein]],,,PMID:20450880,https://www.ncbi.nlm.nih.gov/pubmed/20450880,20450880,,
46,1694984,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of ATM mrna|[naringenin co-treated with bisphenol A] results in increased expression of ATM mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
47,1694985,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,545,ATR,https://ctdbase.org/detail.go?type=gene&acc=545,,,545.0,ATR,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of ATR mrna|[naringenin co-treated with bisphenol A] results in increased expression of ATR mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
48,1694986,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,23621,BACE1,https://ctdbase.org/detail.go?type=gene&acc=23621,,,23621.0,BACE1,9606,Homo sapiens (human),Naringenin results in decreased activity of BACE1 protein,,,PMID:31194956,https://www.ncbi.nlm.nih.gov/pubmed/31194956,31194956,,
49,1694987,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606,Homo sapiens (human),Naringenin results in increased expression of BAK1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
50,1694988,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased expression of BAX protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
51,1694989,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Naringenin inhibits the reaction [tamoxifen results in decreased expression of BAX mrna]|naringenin results in decreased expression of BAX mrna|tamoxifen promotes the reaction [naringenin results in decreased expression of BAX mrna],,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
52,1694990,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BAX mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
53,1694991,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in increased expression of BAX mrna]|naringenin inhibits the reaction [glucose results in increased expression of BAX protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
54,1694992,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BBC3 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BBC3 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
55,1694993,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,9606,Homo sapiens (human),Naringenin inhibits the reaction [[tritolyl phosphates co-treated with NADP] results in decreased activity of BCHE protein],,,PMID:23085349,https://www.ncbi.nlm.nih.gov/pubmed/23085349,23085349,,
56,1695198,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),BCL2 protein results in decreased susceptibility to naringenin|ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein results in decreased susceptibility to naringenin],,,PMID:19124070,https://www.ncbi.nlm.nih.gov/pubmed/19124070,19124070,,
57,1695199,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of BCL2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
58,1695200,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in decreased expression of BCL2 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
59,1695201,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Naringenin promotes the reaction [tamoxifen results in decreased expression of BCL2 mrna],,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
60,1695202,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Naringenin results in decreased expression of BCL2 mRNA,,,PMID:30153467|PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/36235125,30153467|36235125,,
61,1695203,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased expression of BCL2 protein]|naringenin inhibits the reaction [glucose results in decreased expression of BCL2 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
62,1695204,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,597,BCL2A1,https://ctdbase.org/detail.go?type=gene&acc=597,,,597.0,BCL2A1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2A1 mrna|naringenin metabolite results in increased expression of BCL2A1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
63,1695205,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606,Homo sapiens (human),Naringenin results in decreased expression of BCL2L1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
64,1695206,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Naringenin results in increased expression of BDNF mrna|naringenin inhibits the reaction [paraquat results in decreased expression of BDNF mrna],,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
65,1695207,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BIRC5 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BIRC5 mrna|naringenin metabolite results in increased expression of BIRC5 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
66,1695379,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,672,BRCA1,https://ctdbase.org/detail.go?type=gene&acc=672,,,672.0,BRCA1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BRCA1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BRCA1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
67,1695380,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,675,BRCA2,https://ctdbase.org/detail.go?type=gene&acc=675,,,675.0,BRCA2,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BRCA2 mrna|naringenin results in increased expression of BRCA2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BRCA2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
68,1695381,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BTG2 mrna|naringenin metabolite results in decreased expression of BTG2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BTG2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
69,1695382,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CASP2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CASP2 mrna|naringenin results in increased expression of CASP2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
70,1695383,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased activity of CASP3 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
71,1695384,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Naringenin results in increased activity of CASP3 protein,,,PMID:19124070|PMID:22692793,https://www.ncbi.nlm.nih.gov/pubmed/19124070|https://www.ncbi.nlm.nih.gov/pubmed/22692793,19124070|22692793,,
72,1695385,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Naringenin results in increased expression of CASP3 protein modified form,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
73,1695386,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in increased expression of and results in increased cleavage of CASP3 protein]|naringenin inhibits the reaction [glucose results in increased expression of CASP3 mrna]|naringenin inhibits the reaction [glucose results in increased activity of CASP3 protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
74,1695387,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in increased expression of CASP3 mrna]|naringenin results in increased expression of CASP3 mRNA,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
75,1695579,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606,Homo sapiens (human),Naringenin results in increased expression of CASP7 protein modified form,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
76,1695580,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of CASP9 mrna|[naringenin co-treated with bisphenol A] results in increased expression of CASP9 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CASP9 mrna|naringenin results in increased expression of CASP9 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
77,1695581,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased activity of CASP9 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
78,1695582,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Naringenin results in increased activity of CASP9 protein,,,PMID:19124070,https://www.ncbi.nlm.nih.gov/pubmed/19124070,19124070,,
79,1695583,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Naringenin results in increased expression of CASP9 protein modified form,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
80,1695584,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in increased expression of and results in increased cleavage of CASP9 protein]|naringenin inhibits the reaction [glucose results in increased expression of CASP9 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
81,1695585,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [carbon tetrachloride results in decreased activity of CAT protein],,,PMID:23845967,https://www.ncbi.nlm.nih.gov/pubmed/23845967,23845967,,
82,1695586,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Naringenin results in decreased expression of CAT protein,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
83,1695587,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin analog results in increased activity of CAT protein,,,PMID:27417253,https://www.ncbi.nlm.nih.gov/pubmed/27417253,27417253,,
84,1695588,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [arsenic trioxide results in decreased activity of CAT protein],,,PMID:23283742,https://www.ncbi.nlm.nih.gov/pubmed/23283742,23283742,,
85,1695782,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [benzo(a)pyrene results in decreased activity of CAT protein],,,PMID:27206700,https://www.ncbi.nlm.nih.gov/pubmed/27206700,27206700,,
86,1695783,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [cadmium chloride results in decreased expression of CAT protein],,,PMID:19063931,https://www.ncbi.nlm.nih.gov/pubmed/19063931,19063931,,
87,1695784,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [cadmium results in decreased activity of CAT protein],,,PMID:19409769,https://www.ncbi.nlm.nih.gov/pubmed/19409769,19409769,,
88,1695785,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [dietary fats results in decreased activity of CAT protein],,,PMID:30372826,https://www.ncbi.nlm.nih.gov/pubmed/30372826,30372826,,
89,1695786,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased activity of CAT protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
90,1695787,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [lead acetate results in decreased activity of CAT protein],,,PMID:36807407,https://www.ncbi.nlm.nih.gov/pubmed/36807407,36807407,,
91,1695788,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in increased activity of CAT protein]|naringenin results in increased activity of CAT protein,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
92,1695789,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [streptozocin results in decreased activity of CAT protein],,,PMID:29223569,https://www.ncbi.nlm.nih.gov/pubmed/29223569,29223569,,
93,1695790,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9986,Oryctolagus cuniculus (rabbit),"[cholesterol, dietary co-treated with naringenin] affects the expression of CCL2 mRNA",,,PMID:11396955,https://www.ncbi.nlm.nih.gov/pubmed/11396955,11396955,,
94,1695791,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),Naringenin inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein results in increased expression of CCL2]],,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
95,1695983,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CCNB1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
96,1695984,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in decreased expression of CCND1 mrna|naringenin results in decreased expression of CCND1 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
97,1695985,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CCNE1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of CCNE1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
98,1695986,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606,Homo sapiens (human),Naringenin results in decreased expression of CCNE1 mrna|[tamoxifen co-treated with naringenin] results in decreased expression of CCNE1 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
99,1695987,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in decreased expression of CCNG1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
100,1695988,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,902,CCNH,https://ctdbase.org/detail.go?type=gene&acc=902,,,902.0,CCNH,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CCNH mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
101,1695989,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,993,CDC25A,https://ctdbase.org/detail.go?type=gene&acc=993,,,993.0,CDC25A,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CDC25A mrna|naringenin metabolite results in increased expression of CDC25A mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CDC25A mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
102,1695990,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,995,CDC25C,https://ctdbase.org/detail.go?type=gene&acc=995,,,995.0,CDC25C,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CDC25C mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CDC25C mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
103,1695991,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CDK1 mrna|[naringenin co-treated with bisphenol A] results in decreased expression of CDK1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
104,1695992,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CDK4 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
105,1696188,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CDKN1A mrna|naringenin metabolite results in increased expression of CDKN1A mrna|[naringenin co-treated with bisphenol A] results in increased expression of CDKN1A mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
106,1696189,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),Naringenin results in increased expression of CDKN1A mrna|[tamoxifen co-treated with naringenin] results in increased expression of CDKN1A mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
107,1696190,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CDKN2A mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
108,1696191,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),Naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of CFTR mrna]|naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of CFTR protein],,,PMID:31301536,https://www.ncbi.nlm.nih.gov/pubmed/31301536,31301536,,
109,1696192,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CHEK1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CHEK1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
110,1696193,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CHEK2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CHEK2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
111,1696194,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [dietary fats results in decreased expression of CPT1A mrna],,,PMID:30372826,https://www.ncbi.nlm.nih.gov/pubmed/30372826,30372826,,
112,1696195,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8738,CRADD,https://ctdbase.org/detail.go?type=gene&acc=8738,,,8738.0,CRADD,9606,Homo sapiens (human),Naringenin results in increased expression of CRADD mrna|[naringenin co-treated with bisphenol A] results in increased expression of CRADD mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CRADD mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
113,1696196,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in decreased expression of CTNNB1 mrna]|naringenin results in decreased expression of CTNNB1 mRNA,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
114,1696407,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,9606,Homo sapiens (human),[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA,,,PMID:24586459,https://www.ncbi.nlm.nih.gov/pubmed/24586459,24586459,,
115,1696408,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased secretion of CXCL8 protein],,,PMID:19135038,https://www.ncbi.nlm.nih.gov/pubmed/19135038,19135038,,
116,1696409,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606,Homo sapiens (human),Naringenin results in increased expression of CYCS protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
117,1696410,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose affects the localization of CYCS protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
118,1696411,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606,Homo sapiens (human),Naringenin binds to and results in decreased activity of CYP19A1 protein,,,PMID:9435150,https://www.ncbi.nlm.nih.gov/pubmed/9435150,9435150,,
119,1696412,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606,Homo sapiens (human),Naringenin results in decreased activity of CYP19A1 protein,,,PMID:15319488,https://www.ncbi.nlm.nih.gov/pubmed/15319488,15319488,,
120,1696413,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10116,Rattus norvegicus (Norway rat),Naringenin results in decreased activity of CYP19A1 protein,,,PMID:17895526,https://www.ncbi.nlm.nih.gov/pubmed/17895526,17895526,,
121,1696414,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna]|naringenin binds to and results in decreased activity of CYP1A1 protein,,,PMID:11454723,https://www.ncbi.nlm.nih.gov/pubmed/11454723,11454723,,
122,1696415,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Naringenin results in decreased activity of CYP1A1 protein,,,PMID:21053930|PMID:27444380,https://www.ncbi.nlm.nih.gov/pubmed/21053930|https://www.ncbi.nlm.nih.gov/pubmed/27444380,21053930|27444380,,
123,1696416,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090,Mus musculus (house mouse),Naringenin results in increased expression of CYP1A1 mrna|naringenin promotes the reaction [beta-naphthoflavone results in increased expression of CYP1A1 mrna],,,PMID:20930378,https://www.ncbi.nlm.nih.gov/pubmed/20930378,20930378,,
124,1696610,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116,Rattus norvegicus (Norway rat),Naringenin results in decreased activity of CYP1A1 protein,,,PMID:27444380,https://www.ncbi.nlm.nih.gov/pubmed/27444380,27444380,,
125,1696611,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606,Homo sapiens (human),Naringenin results in decreased activity of CYP1A2 protein,,,PMID:21053930|PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/21053930|https://www.ncbi.nlm.nih.gov/pubmed/29753067,21053930|29753067,,
126,1696612,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606,Homo sapiens (human),Naringenin binds to and results in decreased activity of CYP1B1 protein,,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930,,
127,1696613,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090,Mus musculus (house mouse),Naringenin results in increased expression of CYP1B1 mRNA,,,PMID:31621310,https://www.ncbi.nlm.nih.gov/pubmed/31621310,31621310,,
128,1696614,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606,Homo sapiens (human),Naringenin results in decreased activity of CYP2C19 protein,,,PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/29753067,29753067,,
129,1696615,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),Naringenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of flurbiprofen],,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930,,
130,1696616,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),Naringenin results in decreased activity of CYP2C9 protein,,,PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/29753067,29753067,,
131,1696617,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606,Homo sapiens (human),Naringenin results in decreased activity of CYP2E1 protein,,,PMID:33007396,https://www.ncbi.nlm.nih.gov/pubmed/33007396,33007396,,
132,1696618,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Naringenin results in decreased activity of CYP3A4 protein,,,PMID:21053930|PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/21053930|https://www.ncbi.nlm.nih.gov/pubmed/29753067,21053930|29753067,,
133,1696619,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Naringenin results in increased expression of CYP3A4 mRNA,,,PMID:19148864,https://www.ncbi.nlm.nih.gov/pubmed/19148864,19148864,,
134,1696620,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,79758,DHRS12,https://ctdbase.org/detail.go?type=gene&acc=79758,,,79758.0,DHRS12,9606,Homo sapiens (human),Naringenin results in decreased expression of DHRS12 mrna|naringenin results in decreased expression of DHRS12 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
135,1696811,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of DNMT1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of DNMT1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
136,1696812,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1813,DRD2,https://ctdbase.org/detail.go?type=gene&acc=1813,,,1813.0,DRD2,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in decreased expression of DRD2 mrna]|naringenin results in decreased expression of DRD2 mRNA,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
137,1696813,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1869,E2F1,https://ctdbase.org/detail.go?type=gene&acc=1869,,,1869.0,E2F1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of E2F1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of E2F1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
138,1696814,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1871,E2F3,https://ctdbase.org/detail.go?type=gene&acc=1871,,,1871.0,E2F3,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of E2F3 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of E2F3 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
139,1696815,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of EGFR mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of EGFR mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
140,1696816,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of EGFR protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
141,1696817,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of EGR1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of EGR1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
142,1696818,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,28377,Anolis carolinensis (green anole),Naringenin binds to ESR1 protein,,,PMID:11162928,https://www.ncbi.nlm.nih.gov/pubmed/11162928,11162928,,
143,1696819,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,7957,Carassius auratus (goldfish),Naringenin results in increased activity of ESR1 protein,,,PMID:18980245,https://www.ncbi.nlm.nih.gov/pubmed/18980245,18980245,,
144,1696820,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein]|[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein,,,PMID:12650720,https://www.ncbi.nlm.nih.gov/pubmed/12650720,12650720,,
145,1697158,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Naringenin affects the activity of ESR1 protein,,,PMID:15185748,https://www.ncbi.nlm.nih.gov/pubmed/15185748,15185748,,
146,1697159,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Naringenin binds to and results in increased activity of ESR1 protein,,,PMID:10397250|PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/10397250|https://www.ncbi.nlm.nih.gov/pubmed/9751507,10397250|9751507,,
147,1697160,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Naringenin binds to ESR1 protein,,,PMID:19913605|PMID:22692793,https://www.ncbi.nlm.nih.gov/pubmed/19913605|https://www.ncbi.nlm.nih.gov/pubmed/22692793,19913605|22692793,,
148,1697161,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of ESR1 mrna|naringenin metabolite results in increased expression of ESR1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of ESR1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
149,1697162,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [arsenic trioxide results in increased activity of GPT protein],,,PMID:23283742,https://www.ncbi.nlm.nih.gov/pubmed/23283742,23283742,,
150,1697163,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [streptozocin results in increased activity of GPT protein],,,PMID:29223569,https://www.ncbi.nlm.nih.gov/pubmed/29223569,29223569,,
151,1697164,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10090,Mus musculus (house mouse),Naringenin results in decreased expression of GPX1 protein,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
152,1697165,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased expression of GPX1 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
153,1697166,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [cadmium chloride results in decreased expression of GSR protein],,,PMID:19063931,https://www.ncbi.nlm.nih.gov/pubmed/19063931,19063931,,
154,1697167,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased expression of GSR mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
155,1697348,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein|naringenin results in decreased expression of ESR1 mrna|[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of CTSD mrna|naringenin inhibits the reaction [estradiol results in decreased expression of ESR1 protein]|[sb 203580 co-treated with naringenin] results in increased degradation of ESR1 protein|[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of PGR mrna|naringenin inhibits the reaction [cycloheximide results in decreased expression of ESR1 protein]|[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of PSEN2 mRNA,,,PMID:24586459,https://www.ncbi.nlm.nih.gov/pubmed/24586459,24586459,,
156,1697349,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Naringenin promotes the reaction [ESR1 protein binds to ESR1 protein],,,PMID:15713566,https://www.ncbi.nlm.nih.gov/pubmed/15713566,15713566,,
157,1697350,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 mrna|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 protein|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 mRNA alternative form|naringenin results in increased expression of ESR1 mrna|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 protein alternative form|naringenin results in decreased expression of ESR1 mRNA alternative form|naringenin results in decreased expression of ESR1 protein alternative form,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
158,1697351,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Naringenin results in increased activity of ESR1 protein,,,PMID:10854714|PMID:16118406,https://www.ncbi.nlm.nih.gov/pubmed/10854714|https://www.ncbi.nlm.nih.gov/pubmed/16118406,10854714|16118406,,
159,1697352,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090,Mus musculus (house mouse),Naringenin binds to ESR1 protein,,,PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/19913605,19913605,,
160,1697353,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Bisphenol A inhibits the reaction [naringenin results in increased expression of ESR2 mrna]|bisphenol A inhibits the reaction [naringenin metabolite results in increased expression of ESR2 mrna]|naringenin metabolite results in increased expression of ESR2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
161,1697354,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Naringenin binds to and results in increased activity of ESR2 protein,,,PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/9751507,9751507,,
162,1697355,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Naringenin binds to ESR2 protein,,,PMID:12224631|PMID:16566672|PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/12224631|https://www.ncbi.nlm.nih.gov/pubmed/16566672|https://www.ncbi.nlm.nih.gov/pubmed/19913605,12224631|16566672|19913605,,
163,1697540,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Naringenin inhibits the reaction [estradiol binds to ESR2 protein],,,PMID:16566672|PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/16566672|https://www.ncbi.nlm.nih.gov/pubmed/9751507,16566672|9751507,,
164,1697541,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Naringenin results in increased activity of ESR2 protein,,,PMID:16118406|PMID:17716812,https://www.ncbi.nlm.nih.gov/pubmed/16118406|https://www.ncbi.nlm.nih.gov/pubmed/17716812,16118406|17716812,,
165,1697542,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Naringenin results in increased expression of ESR2 mRNA,,,PMID:30153467|PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/36235125,30153467|36235125,,
166,1697543,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in increased expression of ESR2 protein|naringenin results in increased expression of ESR2 protein|[tamoxifen co-treated with naringenin] results in increased expression of ESR2 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
167,1697544,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090,Mus musculus (house mouse),Naringenin binds to ESR2 protein,,,PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/19913605,19913605,,
168,1697545,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8772,FADD,https://ctdbase.org/detail.go?type=gene&acc=8772,,,8772.0,FADD,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of FADD mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
169,1697546,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of FAS mrna|naringenin metabolite results in increased expression of FAS mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of FAS mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
170,1697547,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),Naringenin results in increased phosphorylation of MAPK8 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
171,1697548,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of FASLG mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of FASLG mrna|[naringenin co-treated with bisphenol A] results in increased expression of FASLG mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
172,1697549,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090,Mus musculus (house mouse),Naringenin results in increased expression of FOS mRNA,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
173,1697734,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of FOXO3 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
174,1697735,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,9606,Homo sapiens (human),Naringenin results in decreased activity of G6PD protein,,,PMID:25130191,https://www.ncbi.nlm.nih.gov/pubmed/25130191,25130191,,
175,1697736,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,10116,Rattus norvegicus (Norway rat),[naringenin co-treated with lead acetate] results in decreased activity of G6PD protein|naringenin results in decreased activity of G6PD protein,,,PMID:25228019,https://www.ncbi.nlm.nih.gov/pubmed/25228019,25228019,,
176,1697737,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [cadmium chloride results in decreased expression of G6PD protein],,,PMID:19063931,https://www.ncbi.nlm.nih.gov/pubmed/19063931,19063931,,
177,1697738,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of GADD45A mrna|[naringenin co-treated with bisphenol A] results in increased expression of GADD45A mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of GADD45A mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
178,1697739,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606,Homo sapiens (human),NFE2L2 protein affects the reaction [naringenin results in increased expression of GCLC protein]|naringenin results in increased expression of GCLC protein,,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
179,1697740,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9606,Homo sapiens (human),NFE2L2 protein affects the reaction [naringenin results in increased expression of GCLM protein]|naringenin results in increased expression of GCLM protein,,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
180,1697741,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2765,GML,https://ctdbase.org/detail.go?type=gene&acc=2765,,,2765.0,GML,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of GML mrna|[naringenin co-treated with bisphenol A] results in increased expression of GML mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of GML mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
181,1697742,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2852,GPER1,https://ctdbase.org/detail.go?type=gene&acc=2852,,,2852.0,GPER1,9606,Homo sapiens (human),Naringenin metabolite results in decreased expression of GPER1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
182,1697743,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2852,GPER1,https://ctdbase.org/detail.go?type=gene&acc=2852,,,2852.0,GPER1,9606,Homo sapiens (human),Naringenin results in decreased expression of GPER1 mRNA,,,PMID:30153467|PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/36235125,30153467|36235125,,
183,1697935,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2852,GPER1,https://ctdbase.org/detail.go?type=gene&acc=2852,,,2852.0,GPER1,9606,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in decreased expression of GPER1 mrna|naringenin results in decreased expression of GPER1 protein|[tamoxifen co-treated with naringenin] results in decreased expression of GPER1 protein,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
184,1697936,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606,Homo sapiens (human),Naringenin results in increased expression of GPX2 mrna|[paraquat co-treated with naringenin] results in increased expression of GPX2 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
185,1697937,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2878,GPX3,https://ctdbase.org/detail.go?type=gene&acc=2878,,,2878.0,GPX3,9606,Homo sapiens (human),[paraquat co-treated with naringenin] results in increased expression of GPX3 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
186,1697938,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2880,GPX5,https://ctdbase.org/detail.go?type=gene&acc=2880,,,2880.0,GPX5,9606,Homo sapiens (human),[paraquat co-treated with naringenin] results in increased expression of GPX5 mrna|naringenin results in increased expression of GPX5 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
187,1697939,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2882,GPX7,https://ctdbase.org/detail.go?type=gene&acc=2882,,,2882.0,GPX7,9606,Homo sapiens (human),Naringenin results in increased expression of GPX7 mrna|[paraquat co-treated with naringenin] results in increased expression of GPX7 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
188,1697940,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),Paraquat inhibits the reaction [naringenin results in increased expression of GSR mrna]|naringenin results in increased expression of GSR mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
189,1697941,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2954,GSTZ1,https://ctdbase.org/detail.go?type=gene&acc=2954,,,2954.0,GSTZ1,9606,Homo sapiens (human),Paraquat inhibits the reaction [naringenin results in increased expression of GSTZ1 mrna]|naringenin results in increased expression of GSTZ1 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
190,1697942,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,26762,HAVCR1,https://ctdbase.org/detail.go?type=gene&acc=26762,,,26762.0,HAVCR1,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [carbon tetrachloride results in increased expression of HAVCR1 protein],,,PMID:23845967,https://www.ncbi.nlm.nih.gov/pubmed/23845967,23845967,,
191,1697943,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3099,HK2,https://ctdbase.org/detail.go?type=gene&acc=3099,,,3099.0,HK2,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of HK2 mrna|naringenin metabolite results in increased expression of HK2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of HK2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
192,1697944,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),[paraquat co-treated with naringenin] results in increased expression of HMOX1 mrna|naringenin results in increased expression of HMOX1 mrna|naringenin results in increased expression of HMOX1 protein,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
193,1698130,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),"Naringenin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of HMOX1 protein]|naringenin results in increased expression of HMOX1 protein",,,PMID:15316927,https://www.ncbi.nlm.nih.gov/pubmed/15316927,15316927,,
194,1698131,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Naringenin results in increased expression of and results in increased activity of HMOX1 protein|naringenin results in increased expression of HMOX1 mrna|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringenin results in increased expression of HMOX1 protein]|naringenin inhibits the reaction [TNF protein results in decreased expression of and results in decreased activity of HMOX1 protein]|wortmannin inhibits the reaction [naringenin results in increased expression of HMOX1 protein]|naringenin inhibits the reaction [TNF protein results in decreased expression of HMOX1 mrna],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
195,1698132,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of IGF1R mrna|[naringenin co-treated with bisphenol A] results in increased expression of IGF1R mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
196,1698133,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10090,Mus musculus (house mouse),Naringenin results in increased expression of IKBKB mRNA,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
197,1698134,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of IL1B protein]|naringenin inhibits the reaction [lipopolysaccharides results in increased expression of IL1B mrna],,,PMID:37880698,https://www.ncbi.nlm.nih.gov/pubmed/37880698,37880698,,
198,1698135,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [lead acetate results in increased expression of IL1B protein],,,PMID:36807407,https://www.ncbi.nlm.nih.gov/pubmed/36807407,36807407,,
199,1698136,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of IL6 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of IL6 mrna|[naringenin co-treated with bisphenol A] results in increased expression of IL6 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
200,1698137,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [tyloxapol results in increased expression of IL6 mrna],,,PMID:37076581,https://www.ncbi.nlm.nih.gov/pubmed/37076581,37076581,,
201,1698138,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Naringenin results in decreased susceptibility to IL6 protein|naringenin inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein results in increased expression of ccl2]]|naringenin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein],,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
202,1698326,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10044,Phodopus sungorus,Naringenin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein],,,PMID:22850125,https://www.ncbi.nlm.nih.gov/pubmed/22850125,22850125,,
203,1698327,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606,Homo sapiens (human),Naringenin metabolite results in decreased expression of JUN mrna|naringenin results in decreased expression of JUN mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
204,1698328,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090,Mus musculus (house mouse),Naringenin results in increased expression of JUN mRNA,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
205,1698329,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8850,KAT2B,https://ctdbase.org/detail.go?type=gene&acc=8850,,,8850.0,KAT2B,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of KAT2B mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of KAT2B mrna|[naringenin co-treated with bisphenol A] results in increased expression of KAT2B mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
206,1698330,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3757,KCNH2,https://ctdbase.org/detail.go?type=gene&acc=3757,,,3757.0,KCNH2,9606,Homo sapiens (human),Dofetilide promotes the reaction [naringenin results in decreased activity of KCNH2 protein]|naringenin results in decreased activity of KCNH2 protein|naringenin promotes the reaction [quinidine results in decreased activity of KCNH2 protein]|naringenin promotes the reaction [dofetilide results in decreased activity of KCNH2 protein]|naringenin promotes the reaction [amiodarone results in decreased activity of KCNH2 protein]|azimilide promotes the reaction [naringenin results in decreased activity of KCNH2 protein]|naringenin promotes the reaction [azimilide results in decreased activity of KCNH2 protein]|amiodarone promotes the reaction [naringenin results in decreased activity of KCNH2 protein]|quinidine promotes the reaction [naringenin results in decreased activity of KCNH2 protein],,,PMID:18057881,https://www.ncbi.nlm.nih.gov/pubmed/18057881,18057881,,
207,1698331,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3845,KRAS,https://ctdbase.org/detail.go?type=gene&acc=3845,,,3845.0,KRAS,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of KRAS mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
208,1698332,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [lead acetate results in decreased expression of LHB protein],,,PMID:36807407,https://www.ncbi.nlm.nih.gov/pubmed/36807407,36807407,,
209,1698333,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4025,LPO,https://ctdbase.org/detail.go?type=gene&acc=4025,,,4025.0,LPO,9606,Homo sapiens (human),Paraquat inhibits the reaction [naringenin results in increased expression of LPO mrna]|naringenin results in increased expression of LPO mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
210,1698334,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,80313,LRRC27,https://ctdbase.org/detail.go?type=gene&acc=80313,,,80313.0,LRRC27,9606,Homo sapiens (human),Naringenin results in increased expression of LRRC27 protein|naringenin results in increased expression of LRRC27 mRNA,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
211,1698513,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,120892,LRRK2,https://ctdbase.org/detail.go?type=gene&acc=120892,,,120892.0,LRRK2,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in decreased expression of LRRK2 mrna]|naringenin results in decreased expression of LRRK2 mRNA,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
212,1698514,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,9606,Homo sapiens (human),Naringenin results in increased expression of MAP3K5 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
213,1698515,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of MAPK1 protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
214,1698516,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),Naringenin results in decreased activity of MAPK1 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
215,1698517,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),Naringenin results in decreased phosphorylation of MAPK1 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
216,1698518,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of MAPK1 protein],,,PMID:20450880,https://www.ncbi.nlm.nih.gov/pubmed/20450880,20450880,,
217,1698519,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
218,1698520,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of MAPK3 protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
219,1698521,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),Naringenin results in decreased activity of MAPK3 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
220,1698522,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),Naringenin results in decreased phosphorylation of MAPK3 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
221,1698711,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of MAPK3 protein],,,PMID:20450880,https://www.ncbi.nlm.nih.gov/pubmed/20450880,20450880,,
222,1698712,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
223,1698713,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606,Homo sapiens (human),Naringenin results in increased phosphorylation of MAPK9 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
224,1698714,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4170,MCL1,https://ctdbase.org/detail.go?type=gene&acc=4170,,,4170.0,MCL1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of MCL1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of MCL1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
225,1698715,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of MDM2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of MDM2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of MDM2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
226,1698716,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4194,MDM4,https://ctdbase.org/detail.go?type=gene&acc=4194,,,4194.0,MDM4,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of MDM4 mrna|[naringenin co-treated with bisphenol A] results in increased expression of MDM4 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
227,1698717,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,406933,MIR141,https://ctdbase.org/detail.go?type=gene&acc=406933,,,406933.0,MIR141,9606,Homo sapiens (human),Naringenin metabolite results in decreased expression of MIR141 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
228,1698718,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,406985,MIR200C,https://ctdbase.org/detail.go?type=gene&acc=406985,,,406985.0,MIR200C,9606,Homo sapiens (human),Naringenin metabolite inhibits the reaction [bisphenol A results in increased expression of MIR200C mrna]|naringenin inhibits the reaction [bisphenol A results in increased expression of MIR200C mrna],,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
229,1698719,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of MLH1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of MLH1 mrna|naringenin results in increased expression of MLH1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
230,1698720,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606,Homo sapiens (human),Naringenin results in decreased expression of and results in decreased activity of MMP2 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
231,1698890,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606,Homo sapiens (human),Naringenin results in decreased expression of MMP2 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
232,1698891,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of and results in increased secretion of MMP9 protein]|naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of MMP9 mrna]|naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of MMP9 protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
233,1698892,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),Naringenin results in decreased expression of and results in decreased activity of MMP9 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
234,1698893,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),Naringenin results in decreased expression of MMP9 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
235,1698894,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of MMP9 protein]|naringenin inhibits the reaction [lipopolysaccharides results in increased expression of MMP9 mrna],,,PMID:37880698,https://www.ncbi.nlm.nih.gov/pubmed/37880698,37880698,,
236,1698895,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of MSH2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
237,1698896,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [lead acetate results in decreased expression of MTOR protein],,,PMID:36807407,https://www.ncbi.nlm.nih.gov/pubmed/36807407,36807407,,
238,1698897,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4654,MYOD1,https://ctdbase.org/detail.go?type=gene&acc=4654,,,4654.0,MYOD1,9606,Homo sapiens (human),Naringenin results in increased expression of MYOD1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of MYOD1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of MYOD1 mrna|naringenin metabolite results in increased expression of MYOD1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
239,1698898,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,79923,NANOG,https://ctdbase.org/detail.go?type=gene&acc=79923,,,79923.0,NANOG,9606,Homo sapiens (human),Naringenin results in decreased expression of NANOG protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
240,1698899,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,9606,Homo sapiens (human),Naringenin results in increased expression of PTGS1 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
241,1699066,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4763,NF1,https://ctdbase.org/detail.go?type=gene&acc=4763,,,4763.0,NF1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of NF1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of NF1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
242,1699067,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Naringenin results in increased expression of and affects the localization of NFE2L2 protein|naringenin results in increased expression of NFE2L2 mrna|[naringenin co-treated with paraquat] results in increased expression of NFE2L2 protein,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
243,1699068,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),NFE2L2 protein affects the reaction [naringenin results in increased expression of GCLC protein]|nfe2l2 protein affects the reaction [naringenin results in increased expression of GCLM protein]|naringenin results in increased activity of NFE2L2 protein,,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
244,1699069,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of NFKB1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of NFKB1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
245,1699070,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein],,,PMID:10188978,https://www.ncbi.nlm.nih.gov/pubmed/10188978,10188978,,
246,1699071,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4795,NFKBIL1,https://ctdbase.org/detail.go?type=gene&acc=4795,,,4795.0,NFKBIL1,9606,Homo sapiens (human),Naringenin results in increased expression of NFKBIL1 mrna|naringenin results in increased expression of NFKBIL1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
247,1699072,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4830,NME1,https://ctdbase.org/detail.go?type=gene&acc=4830,,,4830.0,NME1,9606,Homo sapiens (human),Naringenin results in increased expression of NME1 mrna|naringenin results in increased expression of NME1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
248,1699073,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),"Hemin promotes the reaction [naringenin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]]|naringenin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mrna]|naringenin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]",,,PMID:15316927,https://www.ncbi.nlm.nih.gov/pubmed/15316927,15316927,,
249,1699074,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 mrna],,,PMID:10188978|PMID:18274639,https://www.ncbi.nlm.nih.gov/pubmed/10188978|https://www.ncbi.nlm.nih.gov/pubmed/18274639,10188978|18274639,,
250,1699277,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 protein],,,PMID:12512693|PMID:18274639,https://www.ncbi.nlm.nih.gov/pubmed/12512693|https://www.ncbi.nlm.nih.gov/pubmed/18274639,12512693|18274639,,
251,1699278,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:10188978,https://www.ncbi.nlm.nih.gov/pubmed/10188978,10188978,,
252,1699279,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Naringenin results in increased expression of NQO1 protein|naringenin results in increased expression of NQO1 mrna|[paraquat co-treated with naringenin] results in increased expression of NQO1 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
253,1699280,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606,Homo sapiens (human),Naringenin results in increased activity of NR1I2 protein,,,PMID:25455453,https://www.ncbi.nlm.nih.gov/pubmed/25455453,25455453,,
254,1699281,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased cleavage of PARP1 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
255,1699282,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Naringenin results in increased cleavage of PARP1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
256,1699283,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of PCNA mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of PCNA mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
257,1699284,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5226,PGD,https://ctdbase.org/detail.go?type=gene&acc=5226,,,5226.0,PGD,9606,Homo sapiens (human),Naringenin results in decreased activity of PGD protein,,,PMID:25130191,https://www.ncbi.nlm.nih.gov/pubmed/25130191,25130191,,
258,1699285,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606,Homo sapiens (human),[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of PGR mRNA,,,PMID:24586459,https://www.ncbi.nlm.nih.gov/pubmed/24586459,24586459,,
259,1699286,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10116,Rattus norvegicus (Norway rat),Naringenin results in increased expression of PGR mRNA,,,PMID:10397250,https://www.ncbi.nlm.nih.gov/pubmed/10397250,10397250,,
260,1699473,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,55367,PIDD1,https://ctdbase.org/detail.go?type=gene&acc=55367,,,55367.0,PIDD1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of PIDD1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of PIDD1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
261,1699474,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),Naringenin results in increased expression of PON1 mRNA,,,PMID:15169886,https://www.ncbi.nlm.nih.gov/pubmed/15169886,15169886,,
262,1699475,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090,Mus musculus (house mouse),HET0016 inhibits the reaction [naringenin inhibits the reaction [glucose results in decreased expression of PPARA protein]]|naringenin inhibits the reaction [[streptozocin co-treated with dietary fats co-treated with carboxymethylcellulose sodium] results in decreased expression of PPARA protein]|naringenin inhibits the reaction [glucose results in decreased expression of PPARA protein],,,PMID:31063766,https://www.ncbi.nlm.nih.gov/pubmed/31063766,31063766,,
263,1699476,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,100136658,PPARB,https://ctdbase.org/detail.go?type=gene&acc=100136658,,,100136658.0,,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [glucose results in decreased expression of PPARB protein]|naringenin inhibits the reaction [[streptozocin co-treated with dietary fats co-treated with carboxymethylcellulose sodium] results in decreased expression of PPARB protein]|het0016 inhibits the reaction [naringenin inhibits the reaction [glucose results in decreased expression of PPARB protein]],,,PMID:31063766,https://www.ncbi.nlm.nih.gov/pubmed/31063766,31063766,,
264,1699477,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090,Mus musculus (house mouse),HET0016 inhibits the reaction [naringenin inhibits the reaction [glucose results in decreased expression of PPARG protein]]|naringenin inhibits the reaction [glucose results in decreased expression of PPARG protein]|naringenin inhibits the reaction [[streptozocin co-treated with dietary fats co-treated with carboxymethylcellulose sodium] results in decreased expression of PPARG protein],,,PMID:31063766,https://www.ncbi.nlm.nih.gov/pubmed/31063766,31063766,,
265,1699478,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [streptozocin results in decreased expression of PPARG mrna]|naringenin inhibits the reaction [streptozocin results in decreased expression of PPARG protein],,,PMID:29223569,https://www.ncbi.nlm.nih.gov/pubmed/29223569,29223569,,
266,1699479,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8493,PPM1D,https://ctdbase.org/detail.go?type=gene&acc=8493,,,8493.0,PPM1D,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of PPM1D mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of PPM1D mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
267,1699480,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,9606,Homo sapiens (human),Naringenin results in decreased expression of PRDX1 mrna|naringenin results in decreased expression of PRDX1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
268,1699481,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of PRKCA mrna|[naringenin co-treated with bisphenol A] results in increased expression of PRKCA mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
269,1699660,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate affects the localization of PRKCA protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
270,1699661,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate affects the localization of PRKCB protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
271,1699662,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5582,PRKCG,https://ctdbase.org/detail.go?type=gene&acc=5582,,,5582.0,PRKCG,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate affects the localization of PRKCG protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
272,1699663,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842.0,PROM1,9606,Homo sapiens (human),Naringenin results in decreased expression of PROM1 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
273,1699664,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5664,PSEN2,https://ctdbase.org/detail.go?type=gene&acc=5664,,,5664.0,PSEN2,9606,Homo sapiens (human),[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of PSEN2 mRNA,,,PMID:24586459,https://www.ncbi.nlm.nih.gov/pubmed/24586459,24586459,,
274,1699665,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of PTEN mrna|naringenin results in increased expression of PTEN mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
275,1699666,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna],,,PMID:21341175,https://www.ncbi.nlm.nih.gov/pubmed/21341175,21341175,,
276,1699667,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [benzo(a)pyrene results in increased expression of PTGS2 protein],,,PMID:27206700,https://www.ncbi.nlm.nih.gov/pubmed/27206700,27206700,,
277,1699668,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,9232,PTTG1,https://ctdbase.org/detail.go?type=gene&acc=9232,,,9232.0,PTTG1,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of PTTG1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of PTTG1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
278,1699669,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of RB1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
279,1699844,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides affects the localization of and results in increased activity of RELA protein],,,PMID:18274639,https://www.ncbi.nlm.nih.gov/pubmed/18274639,18274639,,
280,1699845,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [benzo(a)pyrene results in increased expression of RELA protein],,,PMID:27206700,https://www.ncbi.nlm.nih.gov/pubmed/27206700,27206700,,
281,1699846,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,56475,RPRM,https://ctdbase.org/detail.go?type=gene&acc=56475,,,56475.0,RPRM,9606,Homo sapiens (human),Naringenin results in increased expression of RPRM mrna|[naringenin co-treated with bisphenol A] results in increased expression of RPRM mrna|naringenin metabolite results in increased expression of RPRM mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of RPRM mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
282,1699847,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,57521,RPTOR,https://ctdbase.org/detail.go?type=gene&acc=57521,,,57521.0,RPTOR,9606,Homo sapiens (human),Naringenin results in increased expression of RPTOR mrna|naringenin results in increased expression of RPTOR protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
283,1699848,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased expression of SERPINE1 mrna],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
284,1699849,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,83667,SESN2,https://ctdbase.org/detail.go?type=gene&acc=83667,,,83667.0,SESN2,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of SESN2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of SESN2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
285,1699850,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606,Homo sapiens (human),Naringenin binds to SHBG protein,,,PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/25349334,25349334,,
286,1699851,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6476,SI,https://ctdbase.org/detail.go?type=gene&acc=6476,,,6476.0,SI,9606,Homo sapiens (human),Naringenin results in decreased activity of SI protein|naringenin binds to and results in decreased activity of SI protein,,,PMID:24412302,https://www.ncbi.nlm.nih.gov/pubmed/24412302,24412302,,
287,1699852,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6477,SIAH1,https://ctdbase.org/detail.go?type=gene&acc=6477,,,6477.0,SIAH1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of SIAH1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
288,1699853,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of SIRT1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of SIRT1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
289,1700036,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,9606,Homo sapiens (human),Naringenin inhibits the reaction [SLC16A1 protein results in increased uptake of benzoic acid],,,PMID:17976262,https://www.ncbi.nlm.nih.gov/pubmed/17976262,17976262,,
290,1700037,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116,Rattus norvegicus (Norway rat),[naringenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of sodium oxybate,,,PMID:17108059,https://www.ncbi.nlm.nih.gov/pubmed/17108059,17108059,,
291,1700038,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606,Homo sapiens (human),Naringenin results in decreased activity of SLC2A1 protein|naringenin inhibits the reaction [SLC2A1 protein affects the transport of glucose],,,PMID:14642735,https://www.ncbi.nlm.nih.gov/pubmed/14642735,14642735,,
292,1700039,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [streptozocin results in decreased expression of SLC2A4 mrna]|naringenin inhibits the reaction [streptozocin results in decreased expression of SLC2A4 protein],,,PMID:29223569,https://www.ncbi.nlm.nih.gov/pubmed/29223569,29223569,,
293,1700040,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6523,SLC5A1,https://ctdbase.org/detail.go?type=gene&acc=6523,,,6523.0,SLC5A1,9606,Homo sapiens (human),Naringenin inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside],,,PMID:17495124,https://www.ncbi.nlm.nih.gov/pubmed/17495124,17495124,,
294,1700041,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6531,SLC6A3,https://ctdbase.org/detail.go?type=gene&acc=6531,,,6531.0,SLC6A3,10116,Rattus norvegicus (Norway rat),Naringenin results in decreased expression of SLC6A3 mrna|naringenin inhibits the reaction [paraquat results in decreased expression of SLC6A3 mrna],,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
295,1700042,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606,Homo sapiens (human),Naringenin inhibits the reaction [SLCO1B1 protein results in increased import of sulfobromophthalein],,,PMID:22394605,https://www.ncbi.nlm.nih.gov/pubmed/22394605,22394605,,
296,1700043,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,28234,SLCO1B3,https://ctdbase.org/detail.go?type=gene&acc=28234,,,28234.0,SLCO1B3,9606,Homo sapiens (human),Naringenin inhibits the reaction [SLCO1B3 protein results in increased import of sulfobromophthalein],,,PMID:22394605,https://www.ncbi.nlm.nih.gov/pubmed/22394605,22394605,,
297,1700044,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,9606,Homo sapiens (human),Naringenin inhibits the reaction [SLCO2B1 protein results in increased uptake of estrone sulfate],,,PMID:23794501,https://www.ncbi.nlm.nih.gov/pubmed/23794501,23794501,,
298,1700045,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6615,SNAI1,https://ctdbase.org/detail.go?type=gene&acc=6615,,,6615.0,SNAI1,9606,Homo sapiens (human),Naringenin results in decreased expression of SNAI1 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
299,1700217,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,9606,Homo sapiens (human),Naringenin results in decreased expression of SNAI2 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
300,1700218,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,10116,Rattus norvegicus (Norway rat),Naringenin results in increased expression of SNCA mrna|naringenin inhibits the reaction [paraquat results in increased expression of SNCA mrna],,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
301,1700219,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,9021,SOCS3,https://ctdbase.org/detail.go?type=gene&acc=9021,,,9021.0,SOCS3,9606,Homo sapiens (human),Naringenin results in increased expression of SOCS3 mrna|naringenin results in increased expression of SOCS3 protein,,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
302,1700220,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090,Mus musculus (house mouse),Naringenin results in decreased expression of SOD1 protein,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
303,1700221,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in increased expression of SOD1 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
304,1700222,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased expression of SOD2 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
305,1700223,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,9606,Homo sapiens (human),Naringenin results in decreased expression of SOX2 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
306,1700224,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased expression of SPP1 mrna],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
307,1700225,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,100301543,ST1A8,https://ctdbase.org/detail.go?type=gene&acc=100301543,,,100301543.0,,9986,Oryctolagus cuniculus (rabbit),Mefenamic acid inhibits the reaction [ST1A8 protein results in increased sulfation of naringenin],,,PMID:11181495,https://www.ncbi.nlm.nih.gov/pubmed/11181495,11181495,,
308,1700226,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in decreased expression of STAT1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
309,1700227,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Naringenin results in decreased phosphorylation of STAT3 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
310,1700396,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Naringenin inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein results in increased expression of ccl2]]|naringenin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein],,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
311,1700397,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),Mefenamic acid inhibits the reaction [SULT1A1 protein results in increased sulfation of naringenin],,,PMID:11181495,https://www.ncbi.nlm.nih.gov/pubmed/11181495,11181495,,
312,1700398,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6818,SULT1A3,https://ctdbase.org/detail.go?type=gene&acc=6818,,,6818.0,SULT1A3,9606,Homo sapiens (human),SULT1A3 protein results in increased sulfation of naringenin,,,PMID:11181495,https://www.ncbi.nlm.nih.gov/pubmed/11181495,11181495,,
313,1700399,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,10474,TADA3,https://ctdbase.org/detail.go?type=gene&acc=10474,,,10474.0,TADA3,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in decreased expression of TADA3 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
314,1700400,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [carbon tetrachloride results in increased expression of TGFB1 protein],,,PMID:23845967,https://www.ncbi.nlm.nih.gov/pubmed/23845967,23845967,,
315,1700401,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [lead acetate results in increased expression of TGFB1 protein],,,PMID:36807407,https://www.ncbi.nlm.nih.gov/pubmed/36807407,36807407,,
316,1700402,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in decreased expression of TH protein]|naringenin results in decreased expression of TH protein,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
317,1700403,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of TNF mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TNF mrna|naringenin metabolite results in increased expression of TNF mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
318,1700404,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased secretion of TNF protein],,,PMID:19135038,https://www.ncbi.nlm.nih.gov/pubmed/19135038,19135038,,
319,1700405,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of TNF],,,PMID:18720166,https://www.ncbi.nlm.nih.gov/pubmed/18720166,18720166,,
320,1700597,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [tyloxapol results in increased expression of TNF mrna],,,PMID:37076581,https://www.ncbi.nlm.nih.gov/pubmed/37076581,37076581,,
321,1700598,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [lead acetate results in increased expression of TNF protein],,,PMID:36807407,https://www.ncbi.nlm.nih.gov/pubmed/36807407,36807407,,
322,1700599,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]|naringenin results in decreased activity of TNF protein|naringenin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein]|naringenin inhibits the reaction [TNF protein results in increased expression of SPP1 mrna]|naringenin inhibits the reaction [TNF protein results in increased expression of SERPINE1 mrna]|zinc protoporphyrin inhibits the reaction [naringenin results in decreased activity of TNF protein]|naringenin inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]|naringenin inhibits the reaction [TNF protein results in decreased expression of and results in decreased activity of HMOX1 protein]|naringenin inhibits the reaction [TNF protein results in decreased expression of HMOX1 mrna],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
323,1700600,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of TNFRSF10B mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TNFRSF10B mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
324,1700601,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8793,TNFRSF10D,https://ctdbase.org/detail.go?type=gene&acc=8793,,,8793.0,TNFRSF10D,9606,Homo sapiens (human),Naringenin results in increased expression of TNFRSF10D mrna|[naringenin co-treated with bisphenol A] results in increased expression of TNFRSF10D mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TNFRSF10D mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
325,1700602,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Naringenin inhibits the reaction [hydrogen peroxide results in increased phosphorylation of and results in increased activity of TP53 protein],,,PMID:15795422,https://www.ncbi.nlm.nih.gov/pubmed/15795422,15795422,,
326,1700603,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Naringenin results in increased expression of and results in increased phosphorylation of TP53 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
327,1700604,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Naringenin results in increased expression of TP53 mrna|[tamoxifen co-treated with naringenin] results in increased expression of TP53 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
328,1700605,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,63970,TP53AIP1,https://ctdbase.org/detail.go?type=gene&acc=63970,,,63970.0,TP53AIP1,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP53AIP1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of TP53AIP1 mrna|naringenin metabolite results in increased expression of TP53AIP1 mrna|naringenin results in increased expression of TP53AIP1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
329,1700782,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7159,TP53BP2,https://ctdbase.org/detail.go?type=gene&acc=7159,,,7159.0,TP53BP2,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP53BP2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
330,1700783,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8626,TP63,https://ctdbase.org/detail.go?type=gene&acc=8626,,,8626.0,TP63,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of TP63 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP63 mrna|naringenin results in increased expression of TP63 mrna|[naringenin co-treated with bisphenol A] results in increased expression of TP63 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
331,1700784,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7161,TP73,https://ctdbase.org/detail.go?type=gene&acc=7161,,,7161.0,TP73,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of TP73 mrna|[naringenin co-treated with bisphenol A] results in increased expression of TP73 mrna|naringenin results in increased expression of TP73 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP73 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
332,1700785,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7173,TPO,https://ctdbase.org/detail.go?type=gene&acc=7173,,,7173.0,TPO,10116,Rattus norvegicus (Norway rat),Naringenin results in decreased activity of TPO protein,,,PMID:26884060,https://www.ncbi.nlm.nih.gov/pubmed/26884060,26884060,,
333,1700786,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7186,TRAF2,https://ctdbase.org/detail.go?type=gene&acc=7186,,,7186.0,TRAF2,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of TRAF2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of TRAF2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
334,1700787,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,80036,TRPM3,https://ctdbase.org/detail.go?type=gene&acc=80036,,,80036.0,TRPM3,9606,Homo sapiens (human),Naringenin results in decreased activity of TRPM3 protein,,,PMID:25361167,https://www.ncbi.nlm.nih.gov/pubmed/25361167,25361167,,
335,1700788,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7248,TSC1,https://ctdbase.org/detail.go?type=gene&acc=7248,,,7248.0,TSC1,9606,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of TSC1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
336,1700789,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [dietary fats results in decreased expression of UCP1 mrna],,,PMID:30372826,https://www.ncbi.nlm.nih.gov/pubmed/30372826,30372826,,
337,1700790,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,9606,Homo sapiens (human),UGT1A1 protein results in increased glucuronidation of naringenin,,,PMID:14557274,https://www.ncbi.nlm.nih.gov/pubmed/14557274,14557274,,
338,1700791,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,10090,Mus musculus (house mouse),Naringenin results in increased expression of UGT1A1 mRNA,,,PMID:31621310,https://www.ncbi.nlm.nih.gov/pubmed/31621310,31621310,,
339,1700980,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575.0,UGT1A10,9606,Homo sapiens (human),UGT1A10 protein results in increased glucuronidation of naringenin,,,PMID:14557274,https://www.ncbi.nlm.nih.gov/pubmed/14557274,14557274,,
340,1700981,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577.0,UGT1A7,9606,Homo sapiens (human),UGT1A7 protein results in increased glucuronidation of naringenin,,,PMID:14557274,https://www.ncbi.nlm.nih.gov/pubmed/14557274,14557274,,
341,1700982,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54576,UGT1A8,https://ctdbase.org/detail.go?type=gene&acc=54576,,,54576.0,UGT1A8,9606,Homo sapiens (human),UGT1A8 protein results in increased glucuronidation of naringenin,,,PMID:14557274,https://www.ncbi.nlm.nih.gov/pubmed/14557274,14557274,,
342,1700983,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606,Homo sapiens (human),UGT1A9 protein results in increased glucuronidation of naringenin,,,PMID:14557274|PMID:18816295,https://www.ncbi.nlm.nih.gov/pubmed/14557274|https://www.ncbi.nlm.nih.gov/pubmed/18816295,14557274|18816295,,
343,1700984,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,9606,Homo sapiens (human),UGT2B15 protein results in increased metabolism of naringenin,,,PMID:7835232,https://www.ncbi.nlm.nih.gov/pubmed/7835232,7835232,,
344,1700985,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,9606,Homo sapiens (human),UGT2B15 protein SNP results in increased metabolism of naringenin,,,PMID:12386133,https://www.ncbi.nlm.nih.gov/pubmed/12386133,12386133,,
345,1700986,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,10116,Rattus norvegicus (Norway rat),UGT2B15 protein results in increased metabolism of naringenin,,,PMID:7574722,https://www.ncbi.nlm.nih.gov/pubmed/7574722,7574722,,
346,1700987,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9986,Oryctolagus cuniculus (rabbit),"[cholesterol, dietary co-treated with naringenin] affects the expression of VCAM1 mRNA",,,PMID:11396955,https://www.ncbi.nlm.nih.gov/pubmed/11396955,11396955,,
347,1700988,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10090,Mus musculus (house mouse),Naringenin inhibits the reaction [tyloxapol results in increased expression of VEGFA mrna],,,PMID:37076581,https://www.ncbi.nlm.nih.gov/pubmed/37076581,37076581,,
348,1700989,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7490,WT1,https://ctdbase.org/detail.go?type=gene&acc=7490,,,7490.0,WT1,9606,Homo sapiens (human),Naringenin metabolite results in increased expression of WT1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of WT1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of WT1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
349,1701177,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,10116,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [benzo(a)pyrene results in increased activity of XDH protein],,,PMID:27206700,https://www.ncbi.nlm.nih.gov/pubmed/27206700,27206700,,
350,1701178,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,9606,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in decreased expression of XRCC5 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
